The Cognitive Neuroscience Journal

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Reach Us +1 (202) 780-3397

Perspective - The Cognitive Neuroscience Journal (2023) Volume 6, Issue 5

Neuromodulators: Unraveling the Connection to Chronic Diseases, with a Focus on Hypertension

Rimas Ivy *

Department of Applied Psychology, VU University Amsterdam, Amsterdam, Netherlands

*Corresponding Author:
Rimas Ivy
Department of Applied Psychology
VU University Amsterdam
Amsterdam, Netherlands

Received:29-Sept-2023, Manuscript No. AACNJ-23- 115907; Editor assigned:03-Oct-2023, PreQC No. AACNJ-23- 115907 (PQ); Reviewed:17-Oct-2023, QC No. AACNJ-23- 115907; Revised:22-Oct-2023, Manuscript No. AACNJ-23- 115907 (R); Published:30-Oct-2023, DOI:10.35841/ aacnj-6.5.169

Citation: Ivy R. Neuromodulators: Unraveling the connection to chronic diseases, with a focus on hypertension. J Cogn Neurosci. 2023;6(5):169

Visit for more related articles at The Cognitive Neuroscience Journal


The intricate network of the human nervous system is governed by an array of messengers, each with its unique role in shaping our bodily functions. Among these messengers are neuromodulators, which not only influence our thoughts and emotions but also play a crucial role in regulating physiological processes. This article delves into the world of neuromodulators, their impact on chronic diseases, and their specific connection to hypertension. Neuromodulators are a class of chemical messengers that regulate neural activity and synaptic transmission. Unlike traditional neurotransmitters, which facilitate rapid and precise communication between neurons, neuromodulators exert broader and longer-lasting effects on neural circuits. These chemical signals often target numerous neurons simultaneously, enabling them to fine-tune the overall state of neural networks. [1].

Neuromodulators and neurophysiology


Release and Diffusion: Neuromodulators are released by specific neurons into the extracellular space, allowing them to influence a large number of neurons in a region. Receptor Activation: Neuromodulators typically bind to G-protein-coupled receptors (GPCRs) on the surfaces of target neurons. GPCRs initiate slower, longer-lasting cellular responses compared to ionotropic receptors. Second Messenger Systems: Activation of GPCRs triggers intracellular signaling cascades via second messenger systems. These cascades can lead to various effects, including changes in gene expression, alterations in ion channel activity, and modification of synaptic strength. Synaptic Plasticity: Neuromodulators are key players in the regulation of synaptic plasticity, which underlies learning and memory processes. They can modulate the strength and efficacy of synaptic connections over time [2].

Neuromodulators and chronic diseases


The influence of neuromodulators extends beyond the realm of neural activity and has a significant impact on chronic diseases. One such condition closely linked to neuromodulation is hypertension, or high blood pressure. Hypertension is a chronic disease characterized by elevated blood pressure levels, often contributing to severe health complications, including heart disease, stroke, and kidney dysfunction. The role of neuromodulators in hypertension is two fold Sympathetic Nervous System Activation: Neuromodulators such as noradrenaline (norepinephrine) and adrenaline (epinephrine) are key players in the activation of the sympathetic nervous system. This activation leads to increased heart rate, cardiac output, and vasoconstriction, all of which elevate blood pressure. Renin-Angiotensin System (RAS) another crucial neuromodulatory system involved in hypertension is the renin-angiotensin system. Angiotensin II, a peptide hormone acting as a neuromodulator, causes blood vessels to constrict, leading to increased blood pressure [3].


Recognizing the role of neuromodulators in hypertension has paved the way for innovative treatment approaches. Medications targeting neuromodulatory pathways, such as beta-blockers and ACE inhibitors, have been developed to manage blood pressure effectively. However, ongoing research is exploring novel neuromodulation-based therapies, including neuromodulatory device implants and advanced pharmacological agents [4].

Neuromodulators, the subtle yet potent regulators of neural and physiological processes, hold the key to understanding and managing chronic diseases like hypertension. By unraveling the intricate web of neuromodulation, researchers and healthcare professionals continue to make strides in developing more effective treatments for chronic diseases, ultimately improving the lives of millions worldwide. As our understanding of neuromodulators expands, so does the potential to unlock new avenues for combating chronic illnesses, bringing us closer to a healthier future.[ [5].


  1. Rana T. Unravelling of nitric oxide signalling: A potential biomarker with multifaceted complex mechanism associated with canine inflammatory bowel disease (IBD). Anaerobe. 2020;66:102288.
  2. Indexed at, Google Scholar, Cross Ref

  3. Hering D, Schlaich M. The role of central nervous system mechanisms in resistant hypertension. Curr Hypertens Rep. 2015;17:1-9.
  4. Indexed at, Google Scholar, Cross Ref

  5. Satarkar D, Patra C. Evolution, expression and functional analysis of CXCR3 in neuronal and cardiovascular diseases: A narrative review. Frontiers in Cell and Developmental Biology. 2022;10:882017.
  6. Indexed at, Google Scholar, Cross Ref

  7. Green AL, Paterson DL. Using deep brain stimulation to unravel the mysteries of cardiorespiratory control. Compr Physiol. 2020;10(3).
  8. Indexed at, Google Scholar, Cross Ref

  9. Di Giovangiulio M, Verheijden S, Bosmans G, et al. The neuromodulation of the intestinal immune system and its relevance in inflammatory bowel disease. Front. Immunol. 2015;6:590.
  10. Indexed at, Google Scholar, Cross Ref

Get the App